Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ersodetug, an antibody targeting Insulin receptor.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Empasiprubart, an antibody targeting C2.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Denecimig, an antibody targeting Factor IX × Factor X.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Delpacibart, an antibody targeting CD71.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Dazukibart, an antibody targeting IFNB1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Brenetafusp, an antibody targeting CD3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Bremzalerbart, an antibody targeting Bet v 1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Belrestotug, an antibody targeting TIGIT.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Rinatabart, an antibody targeting Folate receptor alpha.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Becotatug, an antibody targeting EGFR.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Atisnolerbart, an antibody targeting Bet v 1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Siltartoxatug, an antibody targeting Clostridium tetani tetanus toxin (TeNT).